Loading clinical trials...
Loading clinical trials...
The purpose of this study is to establish an efficient and economic treatment scheme by evaluation of the safety and efficacy of subcutaneous injection of low-dose rhGM-CSF, or of similar injection af...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Shanghai Pulmonary Hospital, Shanghai, China
NCT02461615 · Pulmonary Alveolar Proteinosis
NCT06546098 · Autoimmune Pulmonary Alveolar Proteinosis
NCT06989333 · Pulmonary Alveolar Proteinosis
NCT00901511 · Autoimmune Pulmonary Alveolar Proteinosis
NCT03482752 · Autoimmune Pulmonary Alveolar Proteinosis
Shanghai Pulmonary Hospital
Shanghai
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions